Your browser doesn't support javascript.
loading
A dual role for the N-terminal domain of the IL-3 receptor in cell signalling.
Broughton, Sophie E; Hercus, Timothy R; Nero, Tracy L; Kan, Winnie L; Barry, Emma F; Dottore, Mara; Cheung Tung Shing, Karen S; Morton, Craig J; Dhagat, Urmi; Hardy, Matthew P; Wilson, Nicholas J; Downton, Matthew T; Schieber, Christine; Hughes, Timothy P; Lopez, Angel F; Parker, Michael W.
Afiliação
  • Broughton SE; Australian Cancer Research Foundation Rational Drug Discovery Centre, St. Vincent's Institute of Medical Research, Fitzroy, VIC, 3065, Australia.
  • Hercus TR; The Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, SA, 5000, Australia.
  • Nero TL; Australian Cancer Research Foundation Rational Drug Discovery Centre, St. Vincent's Institute of Medical Research, Fitzroy, VIC, 3065, Australia.
  • Kan WL; The Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, SA, 5000, Australia.
  • Barry EF; The Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, SA, 5000, Australia.
  • Dottore M; The Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, SA, 5000, Australia.
  • Cheung Tung Shing KS; Australian Cancer Research Foundation Rational Drug Discovery Centre, St. Vincent's Institute of Medical Research, Fitzroy, VIC, 3065, Australia.
  • Morton CJ; Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, VIC, 3010, Australia.
  • Dhagat U; Australian Cancer Research Foundation Rational Drug Discovery Centre, St. Vincent's Institute of Medical Research, Fitzroy, VIC, 3065, Australia.
  • Hardy MP; Australian Cancer Research Foundation Rational Drug Discovery Centre, St. Vincent's Institute of Medical Research, Fitzroy, VIC, 3065, Australia.
  • Wilson NJ; CSL Limited, Parkville, VIC, 3010, Australia.
  • Downton MT; CSL Limited, Parkville, VIC, 3010, Australia.
  • Schieber C; IBM Research Australia, Level 5, 204 Lygon Street, Carlton, VIC, 3053, Australia.
  • Hughes TP; IBM Research Australia, Level 5, 204 Lygon Street, Carlton, VIC, 3053, Australia.
  • Lopez AF; South Australian Health and Medical Research Institute and University of Adelaide, Adelaide, SA, 5000, Australia.
  • Parker MW; The Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, SA, 5000, Australia. angel.lopez@sa.gov.au.
Nat Commun ; 9(1): 386, 2018 01 26.
Article em En | MEDLINE | ID: mdl-29374162
ABSTRACT
The interleukin-3 (IL-3) receptor is a cell-surface heterodimer that links the haemopoietic, vascular and immune systems and is overexpressed in acute and chronic myeloid leukaemia progenitor cells. It belongs to the type I cytokine receptor family in which the α-subunits consist of two fibronectin III-like domains that bind cytokine, and a third, evolutionarily unrelated and topologically conserved, N-terminal domain (NTD) with unknown function. Here we show by crystallography that, while the NTD of IL3Rα is highly mobile in the presence of IL-3, it becomes surprisingly rigid in the presence of IL-3 K116W. Mutagenesis, biochemical and functional studies show that the NTD of IL3Rα regulates IL-3 binding and signalling and reveal an unexpected role in preventing spontaneous receptor dimerisation. Our work identifies a dual role for the NTD in this cytokine receptor family, protecting against inappropriate signalling and dynamically regulating cytokine receptor binding and function.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Subunidade alfa de Receptor de Interleucina-3 / Domínios Proteicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Subunidade alfa de Receptor de Interleucina-3 / Domínios Proteicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Austrália